CBLC100

Overview

CBLC100 is an anticancer compound that targets FACT , while inhibiting NF-κB and activating p53 . CBLC100 induces cytotoxicity through p53 -dependent apoptotic and non-apoptotic pathways. CBLC100 is applicable to the research of cancers such as fibrosarcoma.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > MDM-2/p53 | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-124922
• CAS No.: 1197996-83-0
• Molecular Formula: C24H26N2O2
• Molecular Weight: 374.48
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source